Repurposing mebendazole against triple-negative breast cancer CNS metastasis

被引:0
作者
Adrian J. Rodrigues
Sophia B. Chernikova
Yuelong Wang
Thy T. H. Trinh
David E. Solow-Cordero
Ludmila Alexandrova
Kerriann M. Casey
Elizabeth Alli
Abhishek Aggarwal
Tyler Quill
Ashley K. Koegel
Brian J. Feldman
James M. Ford
Melanie Hayden-Gephart
机构
[1] Stanford School of Medicine,Department of Neurosurgery
[2] West China Hospital,Department of Neurosurgery
[3] Sichuan University,High
[4] Sarafan ChEM-H,Throughput Screening Knowledge Center
[5] Stanford University,Vincent Coates Foundation Mass Spectrometry Laboratory
[6] Stanford University School of Medicine,Department of Comparative Medicine
[7] Wake Forest University School of Medicine,Department of Cancer Biology
[8] Stanford University,Department of Materials Science and Engineering
[9] University of California,Department of Pediatric Hematology
[10] University of California,Oncology
[11] Department of Medicine (Oncology),Department of Pediatrics
[12] Stanford School of Medicine,Department of Neurosurgery
[13] Massachusetts General Hospital,Department of Pediatrics
[14] Stanford University,undefined
来源
Journal of Neuro-Oncology | 2024年 / 168卷
关键词
Breast cancer; Leptomeningeal disease; Drug repurposing; Mebendazole;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:125 / 138
页数:13
相关论文
共 287 条
[1]  
Brosnan EM(2018)Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies Ann Transl Med 6 163-950
[2]  
Anders CK(2020)Repurposing of drugs for triple negative breast cancer: an overview Ecancermedicalscience 14 1071-35
[3]  
Spini A(2023)Diagnostic and Therapeutic Updates in Leptomeningeal Disease Curr Oncol Rep 25 937-312
[4]  
Donnini S(2018)Leptomeningeal metastasis from systemic cancer: Review and update on management Cancer 124 21-625
[5]  
Pantziarka P(2010)New strategies in the management of leptomeningeal metastases Arch Neurol 67 305-58
[6]  
Crispino S(2013)Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival Med Oncol 30 408-982
[7]  
Ziche M(2019)Migration rather than proliferation transcriptomic signatures are strongly associated with breast cancer patient survival Sci Rep 9 10989-26664
[8]  
Roy-O'Reilly MA(2020)Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies Neurosurg Clin N Am 31 613-3470
[9]  
Lanman T(2019)Drug repurposing: progress, challenges and recommendations Nat Rev Drug Discov 18 41-e75
[10]  
Ruiz A(2020)The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs Immune Netw 20 e29-4685